Searched for
INHALE DRUG
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...01 Jun, 2026, 01.29 PM IST- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...31 May, 2026, 01.34 PM IST
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...29 May, 2026, 05.30 AM IST
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...29 May, 2026, 12.57 AM IST
- Hantavirus scare a wake-up call: Why India must build its disease X defencesA recent hantavirus outbreak on a cruise ship echoes past pandemic scares. Experts warn Disease X, a future unknown pathogen, is a near cer...24 May, 2026, 11.21 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...06 May, 2026, 11.19 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...29 Apr, 2026, 10.01 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...23 Apr, 2026, 01.38 PM IST
- Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...04 Mar, 2026, 03.47 PM IST
- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...23 Dec, 2025, 12.09 AM IST
- Lupin acquires exclusive rights to develop, manufacture TTP inhalation productsBy leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable inhal...02 Dec, 2021, 11.59 AM IST
- Lupin launches generic antibiotic inhalation solution in USThe company has launched the product as it has received an approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in...13 Jun, 2018, 05.46 PM IST
- Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...06 Dec, 2016, 02.00 AM IST
- 3M in talks to license drug delivery techUS-Based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.04 Dec, 2007, 01.05 AM IST
Load More
